Showing results (121-130 of 279) with videos related to

Sort By:
Pageof 28
Journal of Clinical Microbiology|August 17, 1999
Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibilityR A Howe, M Wootton, P M Bennett, et al.
The Journal of Antimicrobial Chemotherapy|December 20, 1999
Expression and detection of hetero-vancomycin resistance in Staphylococcus aureusR A Howe, M Wootton, T R Walsh, et al.
Clinical EEG (Electroencephalography)|July 1, 1990
Outpatient sleep recording during antiepileptic drug monotherapyM E Drake, A Pakalnis, J E Bogner, et al.
European Journal of Clinical Microbiology|June 1, 1986
In vitro studies of S-25930 and S-25932, two new 4-quinolonesL J Piddock, J M Andrews, J M Diver, et al.
The Journal of Antimicrobial Chemotherapy|March 3, 1999
The in-vitro activity of linezolid (U-100766) and tentative breakpointsR Wise, J M Andrews, F J Boswell, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1988
In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agentsR Wise, J M Andrews, J P Ashby, et al.
The Journal of Antimicrobial Chemotherapy|December 1, 1990
Concentrations of cefpodoxime in plasma and pleural fluid after a single oral dose of cefpodoxime proxetilR Dumont, F Guetat, J M Andrews, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1978
Activity of azlocillin and mezlocillin against gram-negative organisms: comparison with other penicillinsR Wise, A P Gillett, J M Andrews, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopyD Honeybourne, J M Andrews, B Cunningham, et al.
The Journal of Antimicrobial Chemotherapy|December 11, 1999
Tentative minimum inhibitory concentration and zone diameter breakpoints for moxifloxacin using BSAC criteriaJ M Andrews, J P Ashby, G M Jevons, et al.
Pageof 28